Description

Trizipin (meldonium) solution for injections 100 mg/ml. 5 ml. vials №10

Ingredients:

Each 5 ml vial contains 500 mg of meldonium as the active ingredient.

Dosage:

The usual dose is 500 mg-1000 mg per day, administered intravenously. Dosage may vary based on the condition being treated.

Indications:

Trizipin (meldonium) is indicated for the treatment of angina, heart failure, and ischemic heart disease.

Contraindications:

Do not use Trizipin (meldonium) if you have severe liver or kidney disease.

Directions:

Administer Trizipin (meldonium) intravenously. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence:

Studies have shown that meldonium, the active ingredient in Trizipin, has cardioprotective effects by improving energy metabolism and reducing oxidative stress in cardiac cells. Research by Serebruany et al. (2017) demonstrated the efficacy of meldonium in improving exercise capacity in patients with chronic heart failure.

Additional Information:

Trizipin (meldonium) has gained popularity in the sports community for its potential performance-enhancing effects. However, its use in competitive sports is prohibited by the World Anti-Doping Agency (WADA) due to concerns about unfair advantage.

It is essential to consult with a healthcare professional before using Trizipin (meldonium) to determine the appropriate dosage and ensure it is safe and suitable for your medical condition.